2021
DOI: 10.1021/acsomega.1c02303
|View full text |Cite
|
Sign up to set email alerts
|

Degradation-Dependent Controlled Delivery of Doxorubicin by Glyoxal Cross-Linked Magnetic and Porous Chitosan Microspheres

Abstract: Glyoxal cross-linked porous magnetic chitosan microspheres, GMS (∼170 μm size), with a tunable degradation profile were synthesized by a water-in-oil emulsion technique to accomplish controlled delivery of doxorubicin (DOX), a chemotherapeutic drug, to ensure prolonged chemotherapeutic effects. The GMS exhibit superparamagnetism with saturation magnetization, M s = 7.2 emu g –1 . The in vitro swelling and degradation results demo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 68 publications
0
6
0
Order By: Relevance
“…Antimicrobial agents are either physically entrapped within the bioadhesive and released via diffusion, or chemically bound to bioadhesive matrix and their release is stimulus- [74,75] or degradation-dependent. [76,77] Examples of bioadhesives incorporating antimicrobial agents include antimicrobial peptide Tet213 conjugated to methacryloyl-substituted recombinant human tropoelastin (MeTro)/GelMA, [63] and ciprofloxacin physically entrapped in dendronized polyvinylpyrrolidone (PVP)chitosan film (Figure 2A). [78] Nanocomposites are more complicated in design and optimization; however, they have unique features.…”
Section: Strategies For Achieving Antimicrobial Activity In Bioadhesivesmentioning
confidence: 99%
“…Antimicrobial agents are either physically entrapped within the bioadhesive and released via diffusion, or chemically bound to bioadhesive matrix and their release is stimulus- [74,75] or degradation-dependent. [76,77] Examples of bioadhesives incorporating antimicrobial agents include antimicrobial peptide Tet213 conjugated to methacryloyl-substituted recombinant human tropoelastin (MeTro)/GelMA, [63] and ciprofloxacin physically entrapped in dendronized polyvinylpyrrolidone (PVP)chitosan film (Figure 2A). [78] Nanocomposites are more complicated in design and optimization; however, they have unique features.…”
Section: Strategies For Achieving Antimicrobial Activity In Bioadhesivesmentioning
confidence: 99%
“…76 developed a salecan-based magnetic hydrogel for drug release testing of doxorubicin hydrochloride (DOX). Salecan is a water-soluble extracellular glucan that has been copolymerized with vinylacetic acid (VA) and hydroxyethyl acrylate (HEA) in the presence of Fe 3 O 4 @ DOX pH/temperature/magnetic field-responsive release 91 DOX pH/temperature-responsive release magnetic chitosan nanocomposite 92 DOX pH-responsive release magnetic dextran microgels 80 DOX pH/magnetic fieldresponsive MNP@DAS@CPE 93 DOX pH-responsive release Fe 3 O 4 /P(NIPAM-AA-MAPEG) nanogels 94 DOX pH-responsive release glyoxal cross-linked porous magnetic chitosan microspheres 95 DOX pH-responsive release CS/PAA/Fe 3 O 4 nanocomposite 86 5-Fu pH-responsive release Fe 3 O 4 -Dex-MA-g P(NVI/NVCL) 96 5-Fu pH/temperature-responsive ferrogel (methacrylic acid or 2-aminoethyl methacrylate hydrochloride containing ferronanoparticles) 66 5-Fu pH/magnetic fieldresponsive release magnetic gelatin microspheres (MGMs) 20 5-Fu magnetic field-responsive MC-PCL magnetic hydrogel 97 5-Fu pH/magnetic fieldresponsive release CMCS-Fe 3 O 4 microspheres 98 5-Fu magnetic field-responsive release magnetic alginate/chitosan microspheres (DM-ACMSs) 62 DOX magnetic field-responsive release MPTMS-MNP-poly(GMA-g-MACD) 99 5-Fu pH-responsive release agarose nanoparticles and is suitable for hydrogel formation. At pH 4.5, cumulative DOX release reached 76% after 64 h, which was significantly higher than the 16.9 and 10.5% observed at pH 6.8 and 7.4, respectively.…”
Section: Drug Deliverymentioning
confidence: 99%
“…During the incubation period, the PBS solution was withdrawn at pre-defined time intervals to measure the absorbance with a UV/visible spectrophotometer (T70+ UV/Vis Spectrometer, PG Instruments Ltd.) at a wavelength of 358 nm to determine the concentration of TCH released from the composite, in accordance with previous studies. 21,22 The TCH stock concentration of 5−100 µg/mL in PBS solution was initially used to establish the calibration curve from which the drug concentration was extrapolated using an absorbance-concentration calibration curve. The cumulative TCH released from the SiPCL/TCH composite was computed relative to…”
Section: In Vitro Drug Release Experimentsmentioning
confidence: 99%